<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG) and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) are risk factors for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>; however, their impact on these endpoints differs </plain></SENT>
<SENT sid="1" pm="."><plain>Because liver fat and visceral fat are important determinants of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism, we investigated whether these fat compartments and their humoral products, the adipokine adiponectin and the hepatokine fetuin-A, differ in their impact on the <z:chebi fb="105" ids="17234">glucose</z:chebi> categories </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In 330 individuals at risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status was determined by a 2 h 75 g OGTT </plain></SENT>
<SENT sid="3" pm="."><plain>Total-body and visceral fat were precisely quantified by magnetic resonance (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) tomography and liver fat by (1)H-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 210 individuals had <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), 41 isolated IFG, 43 isolated IGT and 36 IFG+IGT </plain></SENT>
<SENT sid="5" pm="."><plain>Total-body fat was not different (p = 0.51), although a small but continuous increase in visceral fat was found among the categories after adjustment for age and sex (NGT: 3.07 +/- 0.10 kg; IFG: 3.11 +/- 0.21 kg; IGT: 3.61 +/- 0.21 kg; IFG+IGT: 3.84 +/- 0.23 kg [SEs], p = 0.03) </plain></SENT>
<SENT sid="6" pm="."><plain>A larger difference was found for liver fat (NGT: 4.73 +/- 0.42%; IFG: 5.86 +/- 0.92%; IGT: 8.65 +/- 0.92%; IFG + IGT: 11.11 +/- 1.01%, p &lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>The differences among the categories were small for adiponectin (p = 0.14), but larger for fetuin-A (p = 0.015) </plain></SENT>
<SENT sid="8" pm="."><plain>Among fat compartments, liver fat (p &lt; 0.0001) and among circulating variables fetuin-A (p = 0.016) were the strongest determinants of the categories </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Liver fat, more than visceral fat, strongly increases when glycaemia and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance move from NGT to isolated IFG, isolated IGT and IFG+IGT </plain></SENT>
<SENT sid="10" pm="."><plain>Because liver-derived circulating fetuin-A determines, although weakly, <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> categories, it is worth searching for hepatokines more strongly predicting <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> </plain></SENT>
</text></document>